NDOTHELIAL cells connected by tight junctions constitute the blood-brain barrier (BBB), which limits the entry of molecules into brain parenchyma depending on molecular size and polarity. 4, 12, 16 Although disruption of the BBB occurs in some pathological states, such as certain brain tumors and neurotrauma, increased vascular permeability can also be induced experimentally by administration of hyperosmolar solutions either intraarterially or directly onto the brain surface. 33, 34 Osmolarity-induced water efflux and shrinkage of capillary endothelial cells, leading to transient opening of the interendothelial cell junctions, is the presumed mechanism of hyperosmolar BBB disruption.
NDOTHELIAL cells connected by tight junctions constitute the blood-brain barrier (BBB), which limits the entry of molecules into brain parenchyma depending on molecular size and polarity. 4, 12, 16 Although disruption of the BBB occurs in some pathological states, such as certain brain tumors and neurotrauma, increased vascular permeability can also be induced experimentally by administration of hyperosmolar solutions either intraarterially or directly onto the brain surface. 33, 34 Osmolarity-induced water efflux and shrinkage of capillary endothelial cells, leading to transient opening of the interendothelial cell junctions, is the presumed mechanism of hyperosmolar BBB disruption.
To achieve experimental BBB disruption, the administered solution must exceed a certain threshold osmolarity and the microvascular endothelium must be exposed to the hyperosmolar agent for a sufficient interval of time. Intracarotid injections of 25% mannitol (1.37 M) over 30 seconds at flow rates that cause transient intravascular hyperosmolarity in the brain region perfused by the internal carotid artery (ICA) have been shown to open the BBB in rats, 34 dogs, 13, 27 and humans. [20] [21] [22] [23] [24] [25] 27, 28 The only clinical application of experimental BBB disruption in humans to date has been in conjunction with experimental intraarterial chemotherapy for malignant brain tumors, and this remains controversial. 11, 32 However, hyperosmolar BBB disruption could potentially be very useful in the delivery of genetically engineered vectors and other substances to the brain.
To achieve optimal interstitial delivery of water-soluble substances to the human brain, a better understanding of the time course and magnitude of BBB disruption following administration of hyperosmolar agents is needed. Currently available methods for qualitative and quantitative assessment of the BBB include staining methods using aniline dyes, 10, 33, 34 quantitative autoradiography, 2, 14, 19 planar scintigraphy, 26 and positron emission tomography (PET). 5, 15, 17, 38 The PET tracer rubidium-82 is a potassium analog that crosses the intact BBB slowly due to its positive charge and extensive hydration. Increased tissue concentrations of 82 Rb after intracarotid urea injection have been demonstrated in primate brain by in vitro tissue analysis and by PET. 38 Furthermore, vasive method to quantify regional blood-tumor barrier permeability in patients with brain tumors before 5, 17 and after treatment with steroids. 15 The short halflife (75 seconds) of 82 Rb permits serial quantitative assessment of BBB permeability by repeated administration of 82 Rb at brief intervals. To determine the magnitude and kinetics of mannitol-induced changes in the BBB of normal primate brain in vivo, we used 82 Rb-PET scanning. The effects of mannitol infusion flow rate and duration of flow on BBB disruption were also examined.
Materials and Methods

Animal Preparation
Approval from the Animal Care and Use Committee of the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institutes of Health (NIH) Radiation Safety Committee was obtained prior to this study. Six adult male baboons, each weighing 25 to 30 kg, received a total of 19 intracarotid BBB disruptions in 10 PET scanning sessions (Table 1 ). All invasive procedures were performed using sterile technique in designated animal surgery facilities.
Anesthesia was induced with an intramuscular injection of ketamine (10 mg/kg), and atropine (0.04 mg/kg) was administered after placement of two intravenous lines. The animals were then intubated and maintained on isofluorane/O 2 anesthesia during placement of a brachial arterial line and throughout the remainder of the study. Intramuscular injections of ketamine (5.0 mg/kg) and xylazine (0.5 mg/kg) were given as needed during transport. Electrocardiogram, arterial blood pressure, respiration, and temperature were monitored continuously and arterial blood gases were analyzed every 30 minutes throughout the study. The animals were maintained under normothermic conditions with recirculating warm water pads during the experiments.
Administration of Mannitol
Intracarotid Mannitol Injections. To reduce the infusion of mannitol to the ipsilateral facial tissues and thus to deliver all injected mannitol to the brain, the ipsilateral external carotid artery (ECA) was ligated immediately distal to its origin from the common carotid artery (CCA) at least 1 week before PET in all but the first two animals. On the scanning day, a No. 5 French angiographic catheter was introduced into one femoral artery using the Seldinger technique, and heparin (800 IU) was administered intravenously. Under fluoroscopy the catheter tip was advanced to the area of the right carotid artery bifurcation. Flow rates of mannitol necessary to displace all blood from the carotid tree were determined by 2-second trial injections of radiographic contrast material (meglumine iothalamate) at set rates (1, 2, and 3 ml/second) under fluoroscopy. The animal was then placed on a mobile PET gurney in the angiography suite, a thermoplastic mask was fitted for head fixation, and the animal was transported to the PET suite where the position of the tip of the intracarotid catheter was confirmed by lateral x-ray film. Mannitol (25%) was injected into the carotid artery with an arterial pressure injector. In nine of the 10 procedures the animal received a second injection of mannitol into the ICA 60 to 76 minutes after the first BBB disruption. Table 1 lists the experimental parameters for intracarotid mannitol infusion.
Systemic Mannitol Injections. Previous studies of electrolyte transport into the brain in hyperosmolar states indicated that mannitol-induced increases in systemic serum osmolarity affect potassium and rubidium uptake by stimulation of specific transport mechanisms. 7 To assess the effect of a systemic increase in serum osmolarity on brain uptake of 82 Rb, three baboons were anesthetized, a catheter was placed transfemorally with the tip in the animal's abdominal aorta, and a bolus injection of 180 ml of mannitol (25%) was given over 1 to 3 minutes. To avoid underestimation of a systemic mannitol effect, more mannitol was used for these studies than for the intracarotid injections (30, 60, 90 , and 120 ml). Positron emission tomography scans were obtained before and serially after mannitol injection. Blood samples, obtained at baseline and serially after injection, were analyzed for osmolarity using a vapor pressure osmometer.
Rubidium-82-Positron Emission Tomography
Positron emission tomography was performed using a scanner with 15 slices, 6.5-mm slice separation, 6.5-mm in-plane reconstructed resolution, and 6-mm axial resolution. Data were corrected for attenuation (using a transmission scan), scatter, randoms, and dead time. An infusion system 37 was used to administer 15 to 50 mCi of 82 Rb from a 82 Sr generator over 30 to 60 seconds into a peripheral vein. Positron emission tomography data collection started automatically when radioactivity reached the head and continued for 6 minutes, during which 17 sequential scans were obtained (six 5-second scans, three 10-second, three 20-second, two 30-second, and three 60-second scans). A baseline 82 Rb study was performed prior to mannitol administration. Additional scans were performed at 8-to 15-minute intervals (to allow for radioactive decay between injections of isotope) for 1 hour following BBB disruption.
Plasma Input Function
Radioactivity in whole blood was measured using an automated blood radioactivity counter developed at NIH. Blood was withdrawn continuously at a rate of 3.8 ml/minute during PET data acquisition and coincidental events were counted by paired NaI detectors. Blood data were corrected for detector dead time, dispersion, and decay. The plasma input function was calculated by scaling the whole blood data by the whole blood/plasma ratio. This ratio was measured as a function of time from hand-drawn samples collected during separate baseline 82 Rb infusions in seven animals. To prevent blood loss, blood from the automated blood counter was collected in a heparinized, sterile glass syringe and reinjected into the animal upon completion of each scan.
Oxygen-15-Water Studies
Regional cerebral blood flow (rCBF) was determined using PET data and an arterial blood curve collected over 4 minutes following intravenous administration of 30 mCi of 15 O-H 2 O. 6 Because 82 Rb images show little anatomical detail, the rCBF images were used to delineate the brain from surrounding soft tissues (Fig. 1A) . To identify the region of brain that was perfused during the intracarotid injection of mannitol for BBB disruption, 5 to 10 mCi of 15 O-H 2 O were mixed with normal saline and injected into the carotid artery over 30 seconds at the same infusion rate that was used for BBB disruption. In one animal, to duplicate the viscosity of the intracarotid injectate, 15 O-H 2 O was mixed with mannitol (25%) before injection. Positron emission tomography images were acquired every 30 seconds for 2 minutes following the intracarotid injection of
Determination of Regions of Interest
The images acquired between 30 and 60 seconds after the intracarotid injection of 15 O-H 2 O were used to define regions of interest (ROIs) within the volume of the brain perfused by intracarotid mannitol (Fig. 1B) . Regions of interest were drawn on four consecutive anatomical PET slices using an automatic edge-finding program. The outermost one to two pixels (size 2 mm ϫ 2 mm/pixel) on all edges of these ROIs were then eliminated to minimize partial volume averaging from surrounding extracerebral tissues and tissues not perfused by mannitol. Identical ROIs were placed on the contralateral, nonperfused hemisphere by reflecting the ipsilateral ROI about the midline, using the rCBF image as reference. In the baboons that received systemic injections of mannitol, whole brain regions were drawn and then reduced by two pixels to avoid partial volume averaging.
Data Analysis
From each 82 Rb study, time-activity curves were generated for each ROI. A correction for the slice-mean timing delay between plasma and tissue data was performed by aligning the early phase of the plasma data to scanner slice count rates, in which both data sets were collected on a 1-second time scale. The tissue data were then analyzed using a model with one tissue compartment 5, 8, 9, 15, 17 with four parameters: K 1 , the unidirectional influx constant, a measure of permeability (l/min/ml); k 2 , the efflux constant (min Ϫ1 ); V p , the plasma volume (ml plasma/ml brain); and ⌬t, the local time shift, that is, the difference between the regional tracer arrival time and the slice-mean arrival time. The final parameter accounts for regional variation in arrival times and, to some extent, for internal dispersion. To obtain values that are representative for a large volume of brain, K 1 and V p values from similar regions in four consecutive slices per animal were averaged.
Sources of Supplies and Equipment
For the mannitol injections we used an arterial pressure injector, model Mark IV or V, manufactured by Medrad Inc., Pittsburgh, PA. Blood samples were analyzed for osmolarity using model 5100B vapor pressure osmometer from Wescor, Inc., Logan, UT. Positron emission tomography was performed using the PC2048-15B scanner available from Scanditronix, Inc., Uppsala, Sweden. An infusion system, provided by CTI, Knoxville, TN, was used to administer the 82 Rb from a O-H 2 O was infused into the internal carotid artery for 30 seconds at flow rates of 1 ml/second (B), 2 ml/second (C), and 3 ml/second (D). The images are acquired 30 to 60 seconds after the start of the infusion and scaled to their own maximum value. At 1 ml/second (A and B) only the ipsilateral hemisphere was perfused. At 2 ml/second (C) activity was clearly visible in the contralateral hemisphere, and at 3 ml/second (D) activity was distributed more uniformly in both hemispheres.
Results
Effect of Perfusion Rate on Mannitol Distribution
To establish the infusion rate of mannitol required to displace all blood from the ICA, we performed a series of trial intracarotid injections during fluoroscopy. In the first two baboons, which had patent ECAs, placement of the catheter tip above the carotid bifurcation in the ICA and an infusion rate of 1 ml/second resulted in reflux of contrast into the ECA. Transient spasm in the ICA occurred in one of these baboons. Placement of the catheter tip below the bifurcation of the CCA and an infusion of 2 ml/second filled both the ICA and ECA and the contrast agent refluxed retrograde in the CCA without producing vasospasm. In all subsequent animals, the ECA was ligated at least 1 week before BBB disruption to avoid loss of mannitol into the ECA. Placement of the catheter tip into the CCA and trial injections with radiographic contrast at a rate of 1 ml/second demonstrated retrograde reflux into the CCA in all of these animals.
The effect of the intracarotid infusion rate on the volume of brain perfused was assessed using Fig. 2A and B) . Sequential studies 22 minutes apart, using the same amount of radioactivity (5 mCi) and the same injection rate (1 cc/second for 30 seconds) showed that the brain volumes perfused were similar, although 26% less 15 O-H 2 O was taken up into brain parenchyma when mixed with mannitol compared to normal saline.
Two animals with ligated ECAs received intracarotid infusions of 5 mCi of 15 O-H 2 O at 1, 2, and 3 ml/second, for 30 seconds. The infusions were separated by 15 minutes to allow the radioactivity to decay to background levels between scans. Figure 2B , C, and D illustrates the close relationship between the rate of intracarotid infusion and the volume of brain perfused in the baboon. At 1 ml/second, only the ipsilateral hemisphere was perfused ( Fig. 2A and B) . At 2 ml/second, activity was clearly visible in part of the contralateral hemisphere (Fig. 2C) , and at 3 ml/second, activity was distributed more uniformly in both hemispheres (Fig. 2D) .
Effect of Mannitol on the 82 Rb Arterial Blood Curve
Hemodynamic changes are expected after injection of a large volume of hyperosmolar solute. Thus, the intravascular volume and the concentration of radioactivity in arterial blood cannot be assumed to remain unchanged following rapid infusion of mannitol. Figure 3 shows a series of typical 82 Rb-plasma input functions for 2 minutes after intravenous injection of 82 Rb in one animal at baseline and at 1, 15, and 30 minutes after BBB disruption. At 1 minute, the area under the arterial blood radioactivity curve after mannitol injection was 72% of baseline; at 15 minutes, it was 80%; and at 30 minutes, 86% of the baseline value. This decrease in arterial blood concentration after BBB disruption occurred in most animals. Changes in arterial blood activity will produce changes in brain tracer concentration independent of permeability changes. Note that the mathematical model that we used to estimate permeability accounts for these changes in the arterial input function.
Failure to consider changes in hematocrit and uptake of 82 Rb into blood cells during data acquisition would produce a systematic error in determining the plasma input function from measured whole blood data. Figure 4 demonstrates the small increase in the whole blood/plasma radioactivity ratio in data obtained from seven studies. Although the absolute values varied between animals due to differences in hematocrit, the net increase during the 6-minute sampling interval was similar for all seven studies. A linear regression model was used to develop a formula for whole blood/plasma ratio (WBPR) based on time (t, in minutes) and hematocrit (h) as follows: WBPR = 0. function for all studies, using the hematocrit measured during each 82 Rb study.
Effect of Mannitol on Systemic Osmolarity
Osmolarity blood curves were obtained in three animals after a bolus injection of 180 ml of 25% mannitol into the abdominal aorta. In all three animals, serum osmolarity rose acutely after the mannitol bolus by approximately 30 mOsm/L. Within 15 to 30 minutes a new plateau was reached at approximately 15 mOsm/L above the baseline value and remained at that level for the remainder of the interval of measurement of 60 minutes.
Effect of Intracarotid Mannitol on BBB Permeability and Plasma Volume
Rubidium-82-PET scans of the same anatomical slice obtained before and after intracarotid mannitol infusion are shown in Fig. 1C and D. The region outlining the entire brain, which was drawn on the rCBF image (Fig.  1A) , is superimposed on all images for anatomical orientation. Intracarotid test injections of 15 O-H 2 O in normal saline were performed for each study and the high uptake area in the 15 O-H 2 O scan (Fig. 1B) was used to define the ROI of brain perfused by mannitol. Whereas little 82 Rb uptake occurred in the region perfused by mannitol from the ICA on the baseline scan (Fig. 1C) , increased uptake is apparent in the ICA distribution after mannitol infusion (Fig. 1D) . Uptake of 82 Rb into extracerebral tissues also increased after mannitol injection, especially in the ipsilateral nasopharyngeal mucosa and temporalis muscle.
We applied compartmental analysis to the time-activity curves from ROIs for each 82 Rb injection, which provided estimates for K 1 and V p for each region. The time courses of changes in K 1 and V p were measured after 18 mannitol infusions that were performed in 10 study sessions (K 1 and V p were not measured in the 15 O-mannitol study; see Table 1 ). A typical time course of K 1 values of mannitolperfused brain in one animal is shown in Fig. 5 . Mean baseline K 1 measured before the first mannitol administration was 4.9 Ϯ 2.4 (standard deviation (SD)) l/min/ml for the mannitol-perfused hemisphere and 4.3 Ϯ 2.5 l/min/ml for the contralateral hemisphere. The mean baseline V p value was 1.71 Ϯ 0.32 ml/100 ml bilaterally. These values were used as a reference for the calculation of the magnitude of change in K 1 after the first mannitol injection. The postmannitol K 1 values were fit to a monoexponential decay function to determine the halftime of reversal of BBB disruption. These functions were also used to estimate K 1 values at the time of the second mannitol injection. These extrapolated baseline K 1 values were 7.5 Ϯ 2.1 l/min/ml for the ipsilateral hemisphere and 6.1 Ϯ 3.4 l/min/ml for the contralateral hemisphere. The extrapolated baseline V p values before the second mannitol administration were 1.66 Ϯ 0.27 ml/100 ml bilaterally. The extrapolated baseline K 1 values were significantly higher than the initial measured baseline values for the ipsilateral hemisphere (p Ͻ 0.05, unpaired Student's ttest). Because of these differences, all quantitative comparisons between disruptions were made by comparing maximum increases in K 1 and V p , namely ⌬K 1 (peak K 1 Ϫ baseline K 1 ) and ⌬V p (peak V p Ϫ baseline V p ).
We were unable to detect any difference in the ⌬K 1 in perfused and contralateral brain between the group of animals that received intracarotid mannitol at 2 ml/second for 30 seconds (four animals) and the group of animals that received injections at 1 ml/second for 60 seconds (six animals). Consequently, the BBB disruption studies are grouped according to the total amount of mannitol administered (Table 2) . In perfused brain, ⌬K 1 was dependent on the total amount of mannitol delivered, resulting in greater increases in K 1 with injection of larger amounts of mannitol. This relationship is shown graphically in Fig. 6 in which ⌬K 1 in perfused brain is plotted against the volume of mannitol infused (in milliliters). The solid line represents linear regression analysis of all ⌬K 1 values and shows a positive correlation between the ⌬K 1 of perfused brain and the mannitol dose (p Ͻ 0.005 on F-test, r = 0.70, y-axis intercept 1.45 l/min/ml, slope 0.132). Table 2 also demonstrates a correlation between contralateral brain ⌬K 1 and the amount of mannitol administered (p Ͻ 0.005 on F-test, r = 0.631, y-axis intercept Ϫ0.11 l/min/ml, slope 0.064). However, the contralateral regions contain areas of perfused and unperfused brain, depending on the rate of injection of intracarotid mannitol (see Fig. 2 ). In Rb injection, and error bars indicate the standard errors for K 1 determined as part of the parameter estimation procedure. The K 1 values of mannitol-perfused brain were fitted to monoexponential decay functions, represented by the smooth line through the data points, which were used to determine the halftime of reversal of blood-brain barrier disruption after mannitol administration. In this case, the baseline K 1 before mannitol administration was 5.9 l/min/ml. Following the 30-second mannitol infusion, K 1 increased by a factor of 2.5 to 14.8 l/min/ml. The halftime for return of K 1 to baseline was 28 minutes. An extrapolated baseline K 1 value of 7.6 l/min/ml was calculated, using the exponential fit of K 1 values (at 63 minutes) obtained after the first mannitol administration. After the 60-second mannitol infusion, K 1 of perfused brain increased over the extrapolated baseline by a factor of 2.9 from 7.6 to 22.4 l/min/ml and the halflife for return to baseline was 33 minutes.
contrast to ⌬K 1 , neither ipsilateral nor contralateral ⌬V p correlated with increasing mannitol dose (ipsilateral ⌬V p : p = 0.259; contralateral ⌬V p : p = 0.501, F-test).
In all studies, the peak K 1 values following intracarotid administration of mannitol were significantly increased over baseline (p Ͻ 0.0001, paired, two-tailed Student's ttest). Similarly, ⌬K 1 and ⌬V p after intracarotid administration of mannitol were always higher in the mannitolperfused hemisphere than in the contralateral hemisphere: p Ͻ 0.0001 and p Ͻ 0.05, respectively, paired two-tailed Student's t-test. The mean (Ϯ SD) halftime of the decrease of ipsilateral ⌬K 1 and ⌬V p following different doses of mannitol was 24.0 Ϯ 14.3 minutes. There was no correlation between the total amount of mannitol delivered and the halftime.
Effect of Systemic Mannitol on Brain K 1
Positron emission tomography was performed in three animals following an intraaortic injection of 180 ml of mannitol (25%). The mean ⌬K 1 for whole-brain regions was 3.9 Ϯ 2.0 l/min/ml and the mean ⌬V p was 0.75 Ϯ 0.36 ml/100 ml.
Discussion
Brain microvascular permeability increases rapidly after intracarotid administration of mannitol and may permit passage of substances, including chemotherapeutic agents, enzymes, and recombinant viral vectors, into the otherwise protected brain interstitial space. In this study, we demonstrate that the influx constant K 1 (a measure of vascular permeability) and V p (vascular volume) can be measured sequentially and noninvasively using 82 Rb-PET scanning in living primates after BBB disruption induced by an intracarotid infusion of hyperosmotic mannitol (25%, 1.37 M).
Our mean baseline K 1 value of 4.9 Ϯ 2.1 l/min/ml is similar to that estimated previously by direct quantification of 86 Rb uptake in brain tissue from normal rats (3.5 Ϯ 0.3 l/min/ml). 7 Quantitative studies of BBB integrity (PET) have also been used in clinical studies to measure vascular permeability in normal brain and in human gliomas at single time points, 5, 15, 17, 38 and our mean baseline K 1 value is consistent with that reported for regions of normal brain in eight patients with brain tumors (4.3 Ϯ 2.2 l/min/ml) assessed by 82 Rb-PET 15 and with that calculated from the 82 Rb extraction data and rCBF in 10 additional patients (5.5 Ϯ 4.3 l/min/ml). 5 The K 1 values provided by these studies are primarily a measure of the permeability-surface area product, with only a small influence of blood flow.
The extent of BBB disruption in our study, that is, ⌬K 1 (peak post-BBB disruption K 1 Ϫ baseline K 1 ), ranged from 6 to 19 l/min/ml brain, depending on the mannitol infusion parameters. Animal studies have used quantitative autoradiography with ␣-aminoisobutyric acid to examine the effect of hyperosmolar BBB disruption in experimental tumors (for review, see Blasberg, et al. (l/ (ml/ (l/ (ml/ Injected (ml) (ml/sec) min/ml) 100 ml) min/ml) 100 ml)
30 (5 animals The experiments in which 60 ml of mannitol was administered consist of two subgroups: 1) injection at 2 ml/second for 30 seconds (four animals), and 2) injection at 1 ml/second for 60 seconds (six animals). Data points from subgroups 1 and 2 are placed slightly to the right and left, respectively, of the 60-minute time point.
ies difficult, experimental parameters similar to ours were used in two quantitative studies in rats. 14, 36 The ⌬K 1 values after mannitol measured by quantitative autoradiography 14, 36 were two to four times higher than our results in primates (mean ⌬K 1 9.4 Ϯ 5.1). Some of the observed difference may be accounted for by the higher capillary density (greater vascular surface area) in rat cortex compared to that in baboon and by a greater amount of white matter in our ROIs than in those used in the rat studies.
The degree of BBB disruption after mannitol infusion has been assessed semiquantitatively in patients undergoing treatment for brain tumors, using 99m Tc-glucoheptonate (Tc-GH) brain scans. 26, 28, 29 A high ratio of Tc-GH activity in disrupted versus undisrupted brain was used to indicate BBB disruption; reported ratios range from 1.0 to 2.17. However, because of the long halflife of 99m Tc (6 hours) and the technical limitations of single-photon imaging and planar scintigraphy, repeated studies and accurate quantitative assessment of BBB disruption are not possible using this technique.
Not only is the magnitude of BBB disruption important, but knowledge of the halftime needed for reconstituting the normal barrier will provide an estimate of the "therapeutic window," namely, the interval during which delivery of a substance from blood across disrupted brain capillaries is greatest. In this manner, the administration of substances normally excluded by the BBB, such as water-soluble chemotherapeutic agents, can be adjusted to optimize net extraction by mannitol-perfused brain and tumor tissue. To calculate the halftime of BBB disruption, repeated measurements of vascular permeability are necessary. Rubidium-82-PET is well-suited for this task because of 82 Rb's short halflife (75 seconds), which permits repeat studies at short time intervals. Closure of the BBB after hyperosmotic disruption was monoexponential with a mean halftime of closure of 24.0 Ϯ 14.3 minutes for mannitol-perfused brain.
Selection of optimal mannitol infusion parameters (that is, flow rate and duration of infusion) may also be important to maximize BBB disruption and the therapeutic effect. In this study, ⌬K 1 and the total dose of mannitol infused into the carotid artery exhibited a linear relationship, regardless of the rate or duration of any particular infusion (Fig. 6 ). This finding is somewhat surprising because complete filling of the ICA and reflux of contrast agent were demonstrated radiographically even at a flow rate of 1 cc/second, the slowest infusion rate used. On the basis of this finding and those observed in rats, 3, 18, 35 it appears that BBB integrity can be viewed as a continuum rather than as an all-or-none phenomenon. 33 The increase in ⌬K 1 that occurs with larger doses of mannitol could be mediated by the opening of a greater number of capillary tight junctions, whereas the opening of an individual tight junction may indeed be an all-or-none event. Alternatively, the higher infusion rates could have resulted in higher intracarotid and microcapillary pressure and contributed to the magnitude of BBB disruption on the basis of hydrostatic effects. 31 Rubidium-82-PET does have some methodological shortcomings. The spatial resolution of our PET images is determined by the high energy of 82 Rb-emitted positrons 30 rather than the resolution capability of the tomograph used in these studies (6.5 mm full width of the photopeak measured at half the maximum count). In addition, large ROIs were used in the analysis of 82 Rb-PET data to ensure sufficient counting statistics. These ROIs included the entire distribution of mannitol-perfused brain in each slice of the ipsilateral hemisphere. Thus, the variability in our estimates of K 1 and V p between animals is probably not due to statistical limitations of 82 Rb-PET, but rather reflects differences in the response to mannitol between animals. A similar interanimal variability has been observed in other studies. 1 Despite differences in the magnitude of ⌬K 1 and ⌬V p , all animals showed a similar temporal pattern of response to BBB disruption (Fig. 5) .
It was assumed in the mathematical model used to calculate ⌬K 1 that the rate constants do not change during each acquisition period (6 minutes). This assumption may produce errors because after BBB disruption, the influx constant rapidly increases and then falls exponentially with a halftime of 20 to 30 minutes. Simulation studies were performed to determine what bias would be introduced in the estimation of K 1 caused by such a change. Tissue activity was simulated from a plasma input function (measured whole blood activity corrected by whole blood/plasma ratio (Fig. 4) ) and the 82 Rb model, in which K 1 was 20 l/min/ml at injection time and dropped exponentially to 5 l/min/ml. For halftimes of 5, 10, and 20 minutes, the percent underestimation in K 1 was 5%, 2.5%, and 1.5%, respectively. Based on these simulations, the assumption of constant parameter values in the model used to fit the data should not introduce a significant error in this study.
Due to the pharmacological similarities between 82 Rb and potassium, potassium-specific transport mechanisms across the BBB may contribute to 82 Rb uptake into brain. Cserr, et al., 7 studied the effect of mannitol-induced systemic hyperosmolarity on brain electrolyte content in nephrectomized rats. They found an unexpectedly high, osmolarity-dependent increase in K 1 for potassium and 86 Rb when serum osmolarity was in the range of 290 to 385 mOsm/L. It was postulated that potassium enters the brain through potassium-specific transport mechanisms to counterbalance electrolyte loss in hyperosmolar states. Blood-brain barrier disruption occurred in that model when systemic serum osmolarity was increased and maintained above 385 mOsm/L for 30 minutes.
To determine whether increased systemic osmolarity influenced 82 Rb uptake in primates, we injected a bolus of mannitol into the abdominal aorta that was significantly larger (180 ml) than the amounts administered into the carotid artery (30-120 ml), and monitored serum osmolarity and K 1 . Even with this large dose of mannitol, serum osmolarity never exceeded 325 mOsm/L and rapidly dropped to a plateau level of less than 15 mOsm/L above the physiological value (290 Ϯ 5 mOsm/L in baboons). Using the mathematical relationship between serum osmolarity (C Osmol ) and K 1 of 86 Rb established by Cserr, et al. 7 (K 1 = 0.0727 C Osmol Ϫ 18), ⌬K 1 caused by systemic changes was estimated to be 2.4 l/min/ml at 1 minute, 1.5 l/min/ml at 10 minutes, and 1.1 l/min/ml at 30 minutes after BBB disruption, assuming that the osmolarityinduced effect is instantaneous. Although these values are based on a comparison between two different species (baboon vs. rat) and different techniques of measuring K 1 (PET vs. tissue electrolyte measurements), the values pre-dicted on the basis of the Cserr, et al., relationship are in the same range as the peak ⌬K 1 values measured in the brains of baboons that received systemic injections of mannitol (3.9 Ϯ 2.0 l/min/ml) and in the contralateral hemisphere of baboons that received intracarotid injections (3.7 Ϯ 2.7 l/min/ml). Thus, the finding of an increase in K 1 (⌬K 1 ) in the contralateral hemisphere after intracarotid mannitol infusions in our animals probably represents a combination of contralateral BBB disruption caused by arterial crossover through the circle of Willis and the effect of systemic osmolarity caused by recirculation of mannitol on specific potassium uptake mechanisms.
Summary
In summary, changes in K 1 and V p in normal primate brain after BBB disruption can be quantified noninvasively over time using 82 Rb-PET. Perfusion parameters can be adjusted using contrast arteriography and 15 O-H 2 O trial injections to predict the target brain region. This study provides: 1) a framework for the noninvasive quantitation of hyperosmotic BBB disruption in human brain and brain tumors; 2) a means to assess the potential therapeutic advantage of the hyperosmolar BBB disruption technique by evaluation of the increase in vascular permeability (⌬K 1 ) and the halftime of barrier closure after mannitol infusion; and 3) an assessment of the effects of variations in the rate and duration of intracarotid infusions of mannitol on the magnitude and duration of BBB disruption.
